MAI Wealth Advisors »

Mineralys Therapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $332k 12k 27.09
2025-12-31 $871 24 36.29
2025-09-30 $682 18 37.94
2025-06-30 $244 18 13.56

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Amazon Call Call Option (Principal) (AMZN)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Call Call Option (Principal) (GOOGL)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr S&p 500 Val Etf (IVE)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for MAI Wealth Advisors

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
FMR
BlackRock
Wellington Management Company
Caption Management
State Street Corporation
Caligan Partners
Vanguard Capital Management
Laurion Capital Management
OrbiMed Advisors
Point72 Asset Management
Franklin Resources
Boothbay Fund Management

View all funds holding Mineralys Therapeutics